KR920701153A - 옥시인돌 유도체 - Google Patents

옥시인돌 유도체

Info

Publication number
KR920701153A
KR920701153A KR1019910700315A KR910700315A KR920701153A KR 920701153 A KR920701153 A KR 920701153A KR 1019910700315 A KR1019910700315 A KR 1019910700315A KR 910700315 A KR910700315 A KR 910700315A KR 920701153 A KR920701153 A KR 920701153A
Authority
KR
South Korea
Prior art keywords
group
oxyindole
lower alkoxy
lower alkyl
phenyl
Prior art date
Application number
KR1019910700315A
Other languages
English (en)
Other versions
KR930011300B1 (ko
Inventor
아끼히로 가와구찌
아쓰시 사또오
마꼬도 가지다니
미쓰기 야마모도
쥰지 야스모도
Original Assignee
고바야시 유끼오
다이호오 야꾸힌 고오교오 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 고바야시 유끼오, 다이호오 야꾸힌 고오교오 가부시끼가이샤 filed Critical 고바야시 유끼오
Publication of KR920701153A publication Critical patent/KR920701153A/ko
Application granted granted Critical
Publication of KR930011300B1 publication Critical patent/KR930011300B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

내용 없음

Description

옥시인돌 유도체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (7)

  1. 일반식
    으로 표시되는 옥시인돌유도체, 식중, R1은 수소원자, 할로겐원자, 저급알킬기 또는 저급알콕시기, R2는 수소원자 또는 저급알킬기, R3는 -CH2-R5(R5는 고리를 형성할 수 있는 알킬기, 벤조디옥사닐기 또는 치환기로서 할로겐원자, 저급알킬기, 저급알콕시기, 히드록시기, 디에틸아미노기, 트리플루오로메틸기, 니트릴기, 니트로기 또는 벤질 옥시기를 복수개 가질 수 있는 페닐기)를 표시함, 또, R2와 R3는 함께 =CH-R5기(R5는 상기와 같다)를 형성할 수 있다.
    R4는 1-프로필부틸기, 피리딜기 또는 치환기로서 저급알콕시, 할로겐원자, 디에틸아미노기, 벤질옥시기, 트리플루오로메틸기, 니트릴기, 니트로기 또는 저급 알킬기를 가질 수 있는 페닐기를 표시함.
  2. 제1항에 있어서, R1은 수소원자 또는 저급알콕시기, R2는 수소원자, R3는 -CH2-R5기(R5는 치환기로서 할로겐원자, 저급알킬기, 저급알콕시기, 히드록시기, 디에틸아미노기를 복수개 가질수 있는 페닐기), R4는 1-프로필 부틸기, 피리딜기 또는 치환기로서 저급알콕시기를 복수개 가질수 있는 페닐기인 것을 특징으로 하는 옥시인돌유도체.
  3. 제1항에 있어서, R1, R2는 수소원자, R3는 -CH2-R5기(R5는 메톡시기를 1∼3개 가지는 페닐기), R4는 4-메톡시페닐기 혹은 페닐기인 것을 특징으로 하는 옥시인돌유도체.
  4. 제1항에 있어서, 1-(4-메톡시벤조일)-3-(4-메톡시벤질)옥시인돌인 것을 특징으로 하는 옥시인돌유도체.
  5. 제1항에 있어서, 1-(4-메톡시벤조일)-3-(2,3,4-트리메톡시벤질)옥시인돌인 것을 특징으로 하는 옥시인돌유도체.
  6. 제1항의 옥시인돌유도체의 유효량과 약리학적 허용 담체를 함유하는 것을 특징으로 하는 뇌기능개선 및 뇌대사부활ㆍ보호제.
  7. 제1항의 옥시인돌유도체의 유효량을 환자에 투여하는 것을 특징으로 하는 뇌기능개선 및 뇌대사 부활, 보호 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개되는 것임.
KR1019910700315A 1989-07-25 1990-07-23 옥시인돌유도체 KR930011300B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP1-191822 1989-07-25
JP19182289 1989-07-25
PCT/JP1990/000945 WO1991001306A1 (fr) 1989-07-25 1990-07-23 Derive oxoindole

Publications (2)

Publication Number Publication Date
KR920701153A true KR920701153A (ko) 1992-08-11
KR930011300B1 KR930011300B1 (ko) 1993-11-29

Family

ID=16281100

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910700315A KR930011300B1 (ko) 1989-07-25 1990-07-23 옥시인돌유도체

Country Status (10)

Country Link
US (1) US5206261A (ko)
EP (1) EP0429685B1 (ko)
JP (1) JP2739188B2 (ko)
KR (1) KR930011300B1 (ko)
AT (1) ATE159718T1 (ko)
CA (1) CA2037923C (ko)
DE (1) DE69031649T2 (ko)
DK (1) DK0429685T3 (ko)
ES (1) ES2110965T3 (ko)
WO (1) WO1991001306A1 (ko)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2100523T3 (es) * 1992-01-16 1997-06-16 Du Pont Merck Pharma Nuevos liberadores de neurotransmisores utiles para la potenciacion de las facultades cognoscitivas.
RU2051151C1 (ru) * 1992-01-16 1995-12-27 Дзе Дюпон Мерк Фармасьютикал Компани Азотсодержащие гетероциклические производные флуорена
FR2686878B1 (fr) * 1992-01-30 1995-06-30 Sanofi Elf Derives du n-sulfonyl oxo-2 indole, leur preparation, les compositions pharmaceutiques en contenant.
US5849780A (en) * 1992-01-30 1998-12-15 Sanofi 1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present
US5310935A (en) * 1992-06-30 1994-05-10 Pharmagroup International Optically active 5-oxygenated (3S)-1,3-dimethyloxindole-3-acetic acids
FR2694004B1 (fr) * 1992-07-21 1994-08-26 Adir Nouvelles 3-(Hydroxybenzylidényl)-indoline-2-ones et 3-(hydroxybenzylidényl)-indoline-2-thiones, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
US5296478A (en) * 1992-10-07 1994-03-22 The Dupont Merck Pharmaceutical Co. 1-substituted oxindoles as cognition enhancers
FR2708606B1 (fr) * 1993-07-30 1995-10-27 Sanofi Sa Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
US6906093B2 (en) 1995-06-07 2005-06-14 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
US6147106A (en) * 1997-08-20 2000-11-14 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
CA2214759C (en) * 1996-01-17 2004-05-18 Taiho Pharmaceutical Co., Ltd. Intimal hypertrophy inhibitors
US20040067531A1 (en) * 1997-08-20 2004-04-08 Sugen, Inc. Methods of modulating protein tyrosine kinase function with substituted indolinone compounds
US6531502B1 (en) 1998-01-21 2003-03-11 Sugen, Inc. 3-Methylidenyl-2-indolinone modulators of protein kinase
WO2000035921A1 (en) 1998-12-17 2000-06-22 F. Hoffmann-La Roche Ag 4,5-pyrazinoxindoles as protein kinase inhibitors
CA2354591A1 (en) 1998-12-17 2000-06-22 F. Hoffmann-La Roche Ag 4-aryloxindoles as inhibitors of jnk protein kinases
KR100649925B1 (ko) 1998-12-17 2007-02-28 에프. 호프만-라 로슈 아게 싸이클린-의존성 키나제, 특히 ｃｄｋ2 의 저해제로서4-알케닐 (및 알키닐) 옥신돌
US6153634A (en) 1998-12-17 2000-11-28 Hoffmann-La Roche Inc. 4,5-azolo-oxindoles
US6689806B1 (en) * 1999-03-24 2004-02-10 Sugen, Inc. Indolinone compounds as kinase inhibitors
US6313310B1 (en) 1999-12-15 2001-11-06 Hoffmann-La Roche Inc. 4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles
CA2396319A1 (en) * 2000-01-18 2001-07-26 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
AU3977001A (en) 2000-02-15 2001-08-27 Sugen Inc Pyrrole substituted 2-indolinone protein kinase inhibitors
FR2807038B1 (fr) * 2000-04-03 2002-08-16 Sanofi Synthelabo Nouveaux derives d'indolin-2-one, leur preparation et les compositions pharmaceutiques les contenant
US6504034B2 (en) 2001-01-23 2003-01-07 Hoffmann-La Roche Inc. Naphthostyrils
AR042586A1 (es) 2001-02-15 2005-06-29 Sugen Inc 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
MXPA04003385A (es) 2001-10-10 2005-04-11 Sugen Inc Derivados de 3-?4-substituido con heterociclilo)-pirrol-2-ilmetilidene?-2-indolinona como inhibidores de cinasa.
WO2006082001A1 (en) 2005-02-07 2006-08-10 F.Hoffmann-La Roche Ag Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
WO2006105795A1 (en) * 2005-04-08 2006-10-12 Leo Pharma A/S Novel indolinone derivatives
MY158766A (en) 2005-04-11 2016-11-15 Xenon Pharmaceuticals Inc Spiro-oxindole compounds and their uses as therapeutic agents
AR053710A1 (es) 2005-04-11 2007-05-16 Xenon Pharmaceuticals Inc Compuestos espiroheterociclicos y sus usos como agentes terapeuticos
JP5460324B2 (ja) 2006-10-12 2014-04-02 ゼノン・ファーマシューティカルズ・インコーポレイテッド 治療剤としてのスピロ−オキシインドール化合物の使用
RU2011119626A (ru) 2008-10-17 2012-11-27 Ксенон Фармасьютикалз Инк. Спирооксиндольные соединения и их применение в качестве терапевтичеких средств
CA2741024A1 (en) 2008-10-17 2010-04-22 Xenon Pharmaceuticals Inc. Spiro-oxindole compounds and their use as therapeutic agents
AR077252A1 (es) 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
MY165579A (en) 2009-10-14 2018-04-05 Xenon Pharmaceuticals Inc Synthetic methods for spiro-oxindole compounds
US9504671B2 (en) 2010-02-26 2016-11-29 Xenon Pharmaceuticals Inc. Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
TW201636017A (zh) 2015-02-05 2016-10-16 梯瓦製藥國際有限責任公司 以螺吲哚酮化合物之局部調配物治療帶狀疱疹後遺神經痛之方法
CN106946759B (zh) * 2017-03-22 2020-02-14 中南大学 2-吲哚酮衍生物及其开环衍生物及合成方法与用途
CN114957084B (zh) * 2022-01-21 2023-05-09 九江学院 一种吲哚酮类化合物及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3428649A (en) * 1968-01-23 1969-02-18 Mcneilab Inc Oxindole derivatives
DE3114351A1 (de) * 1981-04-09 1982-11-04 Hoechst Ag, 6000 Frankfurt "oxindol-derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel mit neuroanaboler wirkung"

Also Published As

Publication number Publication date
ATE159718T1 (de) 1997-11-15
EP0429685B1 (en) 1997-10-29
WO1991001306A1 (fr) 1991-02-07
EP0429685A4 (en) 1991-12-04
AU6032190A (en) 1991-02-22
KR930011300B1 (ko) 1993-11-29
CA2037923A1 (en) 1991-01-26
ES2110965T3 (es) 1998-03-01
EP0429685A1 (en) 1991-06-05
CA2037923C (en) 1996-08-06
US5206261A (en) 1993-04-27
DK0429685T3 (da) 1997-12-15
DE69031649D1 (de) 1997-12-04
DE69031649T2 (de) 1998-02-26
AU617621B2 (en) 1991-11-28
JP2739188B2 (ja) 1998-04-08

Similar Documents

Publication Publication Date Title
KR920701153A (ko) 옥시인돌 유도체
RU2203274C2 (ru) Спироциклические ингибиторы металлопротеаз
RO93855A (ro) Procedeu pentru prepararea de arilciclobutilalchilamina
KR890006590A (ko) 4-아미노피리딘 유도체
KR880700798A (ko) 신규한 인데노티아졸유도체 및 그 제조법
KR900016178A (ko) 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물
TW230771B (ko)
NO921282D0 (no) Benzotiazolderivater og deres anvendelse
DK0413278T3 (da) Anvendelse af xanthinderivater mod mavesår
KR890000401A (ko) 3-(3-하이드록시페닐)-1-프로파논 화합물의 아미노프로판올 유도체 및 그의 제조방법과 상기 화합물을 함유하는 의약조성물
KR950704335A (ko) 포스폰산 디에스테르 유도체(phosphonic diester derivative)
CA1236480B (en) N-NAPHTHOYLGLYCINE DERIVATIVES
KR900012889A (ko) 아르알킬아민 화합물

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20051123

Year of fee payment: 13

LAPS Lapse due to unpaid annual fee